High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study

Table 1 Relationship Between P-LVD or I-LVD and Clinical or Pathological variables in endometrial carcinoma

	N	P-LVD	P-value	I-LVD	P-value
Histologic subtype
Endometrioid	76	20.62 ± 4.04		4.43 ± 1.11
Adenoacanthoma	6	18.28 ± 4.40	0.540	4.08 ± 1.85	0.767
Papillary serous	17	19.71 ± 4.79		4.07 ± 1.27
Clear cell	3	19.67 ± 7.54		4.00 ± 0.47
Stage
I	47	20.30 ± 3.92	0.016	4.25 ± 1.28	0.361
II	26	18.49 ± 4.93		4.15 ± 1.27
III	29	21.79 ± 3.51		4.60 ± 0.83
Grade
Well differentiated	39	20.90 ± 4.57	0.576	4.59 ± 1.09	0.282
Moderately differentiated	32	19.89 ± 4.29		4.04 ± 1.34
Poorly differentiated	31	20.00 ± 3.78		4.42 ± 0.96
Myometrial invasion
≥1/2	56	19.91 ± 4.67	0.543	4.45 ± 1.03	0.415
>1/2	46	20.60 ± 4.08		4.21 ± 1.31
Nodal status
Positive	27	22.08 ± 3.60	0.011	4.76 ± 0.87	0.074
Negative	75	19.62 ± 4.28		4.19 ± 1.23
CD44 expression
<10%	13	16.93 ± 1.84	0.000	3.84 ± 2.19	0.049
10%-70%	55	18.89 ± 3.53		4.14 ± 1.06
>70%	44	23.18 ± 3.96		4.84 ± 0.97
LVSI
Positive	15	25.82 ± 2.79	0.000	4.86 ± 1.22	0.219
Negative	97	19.41 ± 3.73		4.29 ± 1.14
Age
≤55	54	20.00 ± 4.04	0.543	4.42 ± 1.06	0.682
>55	58	20.54 ± 4.40		4.30 ± 1.23

P-LVD, peritumoral lymphatic vessel density; I-LVD, intratumoral lymphatic vessel density.

ISSN: 1471-2407